Filter
517
Filtered Results: 517
Text search:
NASCOP
Featured
Recommendations
83
New Publications
106
Language
Document type
No document type
233
Guidelines
168
Studies & Reports
39
Manuals
33
Fact sheets
18
Strategic & Response Plan
8
Training Material
5
Situation Updates
5
Videos
3
Brochures
2
Infographics
2
Resource Platforms
1
Countries / Regions
Kenya
80
India
29
Nigeria
28
Germany
17
South Africa
17
Global
14
Western and Central Europe
12
Middle East and North Africa
10
Tanzania
8
East and Southern Africa
8
Africa
7
Namibia
7
Rwanda
6
West and Central Africa
6
Brazil
6
Philippines
5
Mozambique
5
Latin America and the Carribbean
5
Eastern Europe and Central Asia
5
Russia
5
Syria
4
Malawi
3
Congo, Democratic Republic of
3
France
3
Uganda
3
Yemen
3
Botswana
3
South Sudan
3
Indonesia
3
Nepal
2
Lesotho
2
Ghana
2
Benin
2
China
2
Congo-Brazzaville
2
Peru
2
Italy
2
Haiti
2
South–East Asia Region
2
Western Pacific Region
2
Bangladesh
2
Eastern Europe
2
Ethiopia
2
Angola
2
Zambia
2
Madagascar
2
Tajikistan
1
Switzerland
1
Colombia
1
Thailand
1
Australia
1
Sierra Leone
1
Togo
1
Cameroon
1
Iran
1
Canada
1
Fiji
1
Senegal
1
Niger
1
Burkina Faso
1
Zimbabwe
1
Cambodia
1
Asia
1
Mauritius
1
Portugal
1
Côte d’Ivoire / Ivory Coast
1
Mali
1
Liberia
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
257
Clinical Guidelines
57
Women & Child Health
18
Key Resources
14
Pharmacy & Technologies
13
Public Health
9
Capacity Building
2
Toolboxes
COVID-19
152
TB
47
HIV
36
Rapid Response
25
Caregiver
13
AMR
9
Mental Health
8
Ebola & Marburg
6
Pharmacy
6
Planetary Health
5
NTDs
4
Refugee
3
Natural Hazards
3
NCDs
3
Conflict
3
Zika
2
Global Health Education
2
Specific Hazards
1
Disability
1
Polio
1
Typhoon
1
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
16 Dec. 2020
This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests to COVID-19 testing. The guidance serves as reference for policymakers, laboratory leads, implementing...
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022
recommended
The overall goal of surveillance, case investigation and contact tracing in this context is to stop human-to-human transmission to control the outbreak. The key objectives of surveillance and case investigation are to rapidly identify cases and clusters in order to provide optimal clinical care; to ...
The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity and mortality in children < 5 years of agehgenerate data to inform vaccine schedule and delivery strategy decisions to op...
BMJ Open Science 2021;5:e100202. doi:10.1136/
bmjos-2021-100202
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progress made in TB prevention and care is not reversed b...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Updated Treatment Guidelines
General practitioners and pediatricians must know the signs and
symptoms of possible pediatric cancer.
